Ambev S.A. ADR (NYSE:ABEV)’s traded shares stood at 1.51 million during the latest session, with the company’s beta value hitting 1.08.The ABEV share’s 52-week high remains $2.85, putting it -25.55% down since that peak but still an impressive 11.45% since price per share fell to its 52-week low of $2.01. The company has a valuation of $35.70B, with an average of 17.93 million shares in intraday trading volume over the past 10 days and average of 28.11 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Ambev S.A. ADR (ABEV), translating to a mean rating of 2.29. Of 3 analyst(s) looking at the stock, 1 analyst(s) give ABEV a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.04.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ambev S.A. ADR (NYSE:ABEV) trade information
The 5-day price performance for the stock is -0.44%, and -3.81% over 30 days. With these gigs, the year-to-date price performance is -18.93%. Short interest in Ambev S.A. ADR (NYSE:ABEV) saw shorts transact 43.98 million shares and set a 1.54 days time to cover.
The extremes give us $2.1 and $2.1 for target low and target high price respectively. As such, ABEV has been trading 7.49% off suggested target high and 7.49% from its likely low.
Ambev S.A. ADR (ABEV) estimates and forecasts
Looking at statistics comparing Ambev S.A. ADR share performance against respective industry, we note that the company has underperformed competitors. Ambev S.A. ADR (ABEV) shares are -2.58% down over the last 6 months, with its year-to-date growth rate lower than industry average at -10.53% against 6.90%. Revenue is forecast to shrink -20.00% this quarter before falling -16.70% for the next one.
Revenue forecast for the current quarter as set by 3 analysts is 4.08B. Meanwhile, for the current quarter, a total of 2 analyst(s) estimate revenue growth to 4.82B.Earnings reports from the last fiscal year show that sales brought in 4.24B and 4.04B respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -3.70% before jumping 19.50% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -0.73% for the past 5-year period. While 2024 is set for a -12.14% return in earnings, projections for the next 5 years are at 2.55% annually.
ABEV Dividends
Ambev S.A. ADR has its next earnings report out on 2024-Oct-31. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Ambev S.A. ADR has a forward dividend ratio of 0.00, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 3.98%.
Ambev S.A. ADR (NYSE:ABEV)’s Major holders
The next major institution holding the largest number of shares is HARDING LOEVNER LP with 115.34 million shares, or about 0.7324% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $236.45 million.
We also have First Eagle Global Fund and First Eagle Overseas Fund as the top two Mutual Funds with the largest holdings of the Ambev S.A. ADR (ABEV) shares. Going by data provided on Jul 31, 2024, First Eagle Global Fund holds roughly 157.16 shares. This is just over 1.00% of the total shares, with a market valuation of $356.74 million. Data from the same date shows that the other fund manager holds a little less at 72.9, or 0.46% of the shares, all valued at about 165.48 million.
